Aug 10, 2026 06:49AM
Aug 6, 2026 08:00AM
Jul 13, 2026 08:00AM
Jul 13, 2026 08:00AM
May 7, 2026 04:05PM
Apr 16, 2026 06:02AM
Apr 16, 2026 06:00AM Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
Apr 14, 2026 04:05PM
Apr 14, 2026 04:05PM
Jan 21, 2026 08:00AM
Jan 21, 2026 08:00AM
Oct 16, 2025 08:34AM
Oct 16, 2025 08:30AM
Aug 13, 2025 08:30AM Aligos begins phase 2 trial for hepatitis B treatment ALG-000184
Aug 13, 2025 08:30AM
May 6, 2025 08:00AM
Mar 12, 2025 06:41AM
Nov 6, 2024 04:05PM
Oct 22, 2024 08:00AM
Sep 24, 2024 07:52AM
Sep 12, 2024 07:40AM Piper Sandler Reiterates Overweight Rating on Aligos Therapeutics Inc. (ALGS)
Jul 19, 2024 02:34PM
Jun 6, 2024 07:47AM
May 28, 2024 09:30AM
May 28, 2024 09:30AM
Nov 2, 2023 04:05PM
Sep 21, 2023 07:34AM
Jun 22, 2022 08:04AM Aligos Therapeutics Inc. (ALGS) Presents 28-Day Safety, Efficacy and Pharmacokinetic Clinical Data for ALG-000184
Jun 22, 2022 08:00AM
Jun 22, 2022 08:00AM
Jun 29, 2021 09:27AM

330,681 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All